Please login to read the full article.
Scrip Regulatory Affairs
Canada consults on plans to schedule device company inspections based on risk
12 August 2011
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Commission consults on plans to ensure EU-wide equivalence of imported active substances
- Draft EU regulation sets out uniform conditions for various pharmacovigilance activities
- Canada consults on use of foreign review reports in evaluation of drugs, devices
- Canada helps importers, distributors prepare for initial GMP inspection
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
